Growth Hormone Peptides Do More Than Release GH: Cardiovascular, Appetite, and Sleep Effects | Research

The takeaway

GH secretagogues have significant non-endocrine activities including cardiovascular protection, appetite stimulation, sleep improvement, and anti-aging effects mediated through widespread receptor distribution.

Multi-system effects
Beyond GH release, secretagogues show cardiovascular protection, appetite stimulation, sleep improvement, and anti-aging properties

What the researchers found

GH secretagogues have clinically significant non-endocrine effects including cardiovascular protection, orexigenic (appetite-stimulating) activity, sleep architecture improvement, and potential anti-aging properties mediated by widespread GHS receptor distribution.

Why it matters

Understanding the full spectrum of GH secretagogue effects is essential for their therapeutic development. The non-endocrine effects may be as clinically important as GH release, expanding potential applications to cardiovascular disease, eating disorders, and age-related decline.

How the study worked

Comprehensive review of human clinical and preclinical data on the endocrine (GH, PRL, ACTH release) and non-endocrine (cardiovascular, appetite, sleep, aging) effects of GH secretagogues.

What this study cannot tell us

Review based on a mix of clinical and preclinical data. Some non-endocrine effects were preliminary. Long-term consequences of multi-system activation not fully understood.

How to read the evidence

Moderate evidence from a review combining human clinical data and preclinical findings, with individual non-endocrine effects at varying evidence levels.

When this study was published

Published in 1999. Many non-endocrine effects described have been confirmed and further characterized, particularly cardiovascular and appetite effects via ghrelin receptor.

The bigger picture

GH secretagogues were originally developed for a single purpose — releasing GH. The discovery of their diverse biological effects has transformed them into potential multi-target therapeutics for aging, heart disease, and metabolic disorders.

Questions still open

Can specific GH secretagogues be optimized for non-endocrine effects?
Are the cardiovascular benefits independent of GH release?
Could GH secretagogues serve as multi-target anti-aging agents?

Common questions

What effects do GH peptides have besides releasing growth hormone?

They can protect the heart, increase appetite, improve sleep quality, and may have anti-aging properties. These effects come from receptors throughout the body, not just in the pituitary gland.

Are the side effects of GH peptides related to these extra activities?

Yes — increased appetite and changes in cortisol/prolactin are direct consequences of receptor activation beyond the pituitary. Understanding this helps manage expectations and side effects.

Read the original research

Endocrine and non-endocrine activities of growth hormone secretagogues in humans.

Hormone research, 51 Suppl 3, 9-15

View on PubMed ↗

Citation

Ghigo, E; Arvat, E; Broglio, F; Giordano, R; Gianotti, L; Muccioli, G; Papotti, M; Graziani, A; Bisi, G; Deghenghi, R; Camanni, F. (1999). Endocrine and non-endocrine activities of growth hormone secretagogues in humans.. Hormone research, 51 Suppl 3, 9-15.